-
Company Insights
NewUnited Overseas Bank Limited – Digital Transformation Strategies
United Overseas Bank Digital Transformation Strategies Overview United Overseas Bank is exploring the use of advanced technologies such as blockchain, artificial intelligence, big data, and cloud to increase its operational flexibility and efficiency. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of United Overseas Bank was estimated at $835 million in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and...
-
Innovation Ranking
Innovation Ranking – Orient Overseas (International) Ltd
Orient Overseas (International) Ltd (OOIL), a subsidiary of Faulkner Global Holdings Limited is a transport and logistics service providing company. The company engages in the provision of container transport and logistics services, property investment services, and operating of ports and terminals. It involves in transportation businesses and the leasing of equipment. The company provides innovative freight management services, cargo handling, trucking, warehousing and leading-edge IT solutions. OOIL offers information on shipping schedules and vessel tracking for shippers and logistics services....
-
Sector Analysis
India Green Fashion Market Summary, Competitive Analysis and Forecast to 2028
Green Fashion in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Green Fashion is defined as clothing, footwear, and accessories that are sustainably produced and consumed by considering both environmental and socioeconomic factors. Green Fashion products are made from various eco-friendly materials such as biofiber,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Cryoglobulinemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Cryoglobulinemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Cryoglobulinemia Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Emphysema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Emphysema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Emphysema Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Systemic Sclerosis (Scleroderma) Drug Details: Belimumab (Benlysta) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-044 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-044 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-044 in Epilepsy Drug Details: OPL-044 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-053 in Insomnia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-053 in Insomnia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-053 in Insomnia Drug Details: OPL-053 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-015 in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-015 in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-015 in Pain Drug Details: OPL-015 is under development for the treatment of...
-
Company Insights
Innovation and Patenting activity of United Overseas Bank Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of United Overseas Bank Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...